A Moment With Our New President, Dr. Omar Khan

For someone who has no idea how to answer the question ‘where do you see yourself in 5 years’, it is difficult to comprehend the magnitude of 88 years.  That’s the length of time the Delaware Academy of Medicine has been around. I joined not because of this history, but because of what the foundation established by this history meant for the future.  I joined when my friend and colleague Dr. Arun Malhotra collared me in the parking lot of the Academy office (part of the Christiana Hospital campus) and suggested I do so.  Not being a joiner by nature, I still agreed to be part of this group which my smart and dynamic colleague belonged to. I discovered there other smart, dynamic colleagues, keenly interested in quite an unusual question: how to continuously be relevant to the membership, to the community, to Delaware- even if it meant challenging and reinventing one’s mission.

Over the last 10 years I have had the privilege of learning from the finest leaders from medicine, dentistry, public health, nursing, social sciences, and indeed all disciplines connected with the health sciences.  Your Delaware Academy of Medicine has grown to encompass the broadest possible mission of serving health by also becoming the Delaware Public Health Association (DPHA).  We have formed partnerships with all those interested in the same as us: serving and improving the health of our community.

I am incredibly grateful to the leadership of Dr. Dan Meara, a scholar, gentleman and friend.  His steady leadership and wisdom over the last few years have been instrumental in maintaining our strength.  Our incredible Board- which is really 2 Boards, that of the Academy of Medicine, and the Advisory Council of the DPHA- deserve our heartfelt thanks for volunteering on behalf of the Delaware community to keep our work on track.

The staff of the Academy are a well-kept secret, which I intend to make less well-kept during my tenure. They are an exceptional team, comprising Tim Gibbs (Executive Director), Kate Smith, Elizabeth Lenz, Elizabeth Healy- all of whom put together our diverse programming from Mini Medical School to the University of Delaware’s Osher Lifelong Learning Institute; plan, edit, and published the acclaimed and popular Delaware Journal of Public Health; administer student loans for medical and dental students; host a continual stream of student interns; optimize our partner relationships; keep us on sound financial footing – and oh yes, spend most waking minutes thinking about new and innovative ways to do what we do.  It’s an always-exhilarating (occasionally exhausting J) place to work.

And that is just the local work. Add to that our leadership role in the American Public Health Association, partnership with the National Academy of Medicine and Fogarty International Center of the NIH; and extensive national involvement in various national organizations on the part of our Board and Advisory Council Members. We truly Think Locally and Act Globally.

Some of the best moments in caring for others is getting to know one’s colleagues.  As the practice environment has changed, as have we.  Fewer community physicians come to the hospital, yet the health systems are now more engaged in the health of communities. I see incredible possibilities for collaboration ahead- for delivering increasing value to our patients and communities. And it remains rooted in the power of relationships- the unique Delaware way of accomplishing important tasks through the personal touch.

Over the next couple of years, I hope to get to know as many of you as possible, and I hope you will do likewise.  Our team is embedded in the fabric of all you do and those you serve.  My bio is here, and closeby you will find profiles of all our Board Members.

This space is intended as a place for dialogue – for con khan-versation.  Having suffered through countless ‘Wrath of Khan’ jokes since 1982, I figured it’s my turn.   So, talk to us. Tell us what you like, what you’d like us to be, where you’d like us to go. What would you like us to do the next 88 years?  Keep it interesting, fun, constructive.  That’s the plan.  Let’s drive!

2018 Public Health Recognition – Jewish Family Services of Delaware

At the 88th Annual Meeting of the Delaware Academy of Medicine / Delaware Public Health Association the work of Jewish Family Services of Delaware was accepted by their CEO, Basha Silverman.

Started by the Delaware Academy of Medicine in 2010, the Public Health Recognition Award is given to a Delaware nonprofit organization who has shown outstanding leadership and dedication to the improvement of our community.

Previous awardees include:

  • 2010 The Heart Truth Delaware
  • 2011 Delaware Breast Cancer Coalition
  • 2012 Immunization Coalition of Delaware
  • 2013 St. Michael’s School and Nursery
  • 2014 Vietnam Veterans of America, Chapter 83, Gold Star Program
  • 2015 Gift of Life Donor Program
  • 2016 Hon. Jack Markell – Governor of Delaware 2009-2017
  • 2017 American Lung Association of the Mid-Atlantic

Jewish Family Services of Delaware (JFS) is multi-faceted social service organization that embraces and fulfills a mission to strengthen individuals, families, and the community by providing counseling and support services. Our services include outpatient therapy, case management, workforce development, refugee resettlement, adoption, and prevention education. Our work has been accomplished person-by person, need by need and always with compassion, skill and commitment to individual integrity.

As a result, our agency today is strong and stable. Our programs and policies are designed to remove barriers that may inhibit people in vulnerable situations from accessing needed support. We are all responsible for one another. Inspired by this fundamental Jewish value, Jewish Family Services assists individuals and families through life transitions, helping youth and children grow stronger, and ensuring the safety and dignity of older adults. JFS supports families of all backgrounds as they deal with basic human needs, life transitions, and mental health issues. JFS has the unique privilege of representing the tzedakah (justice), compassion, and loving kindness of the Jewish people to the broader community. Many JFS clients are not Jewish, but all of them learn what it means to be Jewish: the beauty of our traditions and our commitment to tikkun olam, building a better world.

Basha Silverman, Chief Executive Officer of Jewish Family Services of Delaware, has an exemplary career of over 16 years in non-profit social services and Jewish communal service.

Prior to joining JFS, Basha was the Vice President of Strategic Expansion at Jewish Family & Children’s Services of Philadelphia where she was responsible for driving the Agency’s program development and visions for growth as well as generating revenue by leading a robust initiative. A native Delawarean, Basha has deep personal and professional connections in the First State. She spent 12 years at Brandywine Counseling and Community Services, serving in many capacities. She is founder of Delaware’s first coalition aimed at designing a gender specific, health focused response to victims of trauma, and has developed programs for HIV/AIDS, substance abuse, and mental health in Delaware and Pennsylvania. She was named 2013 Power Woman of the Year by Main Line Magazine.

Basha is a graduate of Brandywine High School, University of Delaware, and Bryn Mawr Graduate School of Social Work and Social Research. She and her husband Jesse have two daughters, Noa and Mira.

2018 Lewis B. Flinn President’s Award – Nicholas Petrelli, MD, FACS

At the 88th Annual Meeting of the Delaware Academy of Medicine / Delaware Public Health Association, Dr. Nicholas Petrelli was honored with the Academy’s highest award named in honor of Lewis B. Flinn, first president of the Academy of Medicine.

Over the past 18 years, Dr. Petrelli has been a nationally recognized leader in the fight against cancer and developed the Helen F. Graham Cancer Center & Research Institute into a national model of cancer care, prevention, outreach and research.

Thanks to Dr. Petrelli’s leadership and partnerships with others in the state and elsewhere, Delaware’s cancer mortality rate is now dropping twice as fast as the national rate. The state is outpacing the nation in reducing deaths from a number of cancers, including breast cancer and colorectal cancer. The State has gone from number one in cancer mortality to number 18. Among his many accomplishments:

• Established the Helen F. Graham Cancer Center & Research Institute as one of the first cancer centers in the nation selected for the National Cancer Institute Community Centers Program that helped to shape the way cancer care is delivered across the country.

• Through an unprecedented public-private partnership, the Helen F. Graham Cancer Center & Research Institute was integral in making sure all people in Delaware receive care for cancer no matter their income level or health insurance status.

• Led the development of 14 multidisciplinary disease site centers and selection as one of three community cancer centers to participate in the Cancer Genome Atlas Project.

•Achieved one of the highest National Cancer Institute clinical trials participation rates in the country at 24 percent, well above the national rate of 4 percent.

• Developed the first statewide High Risk Family Cancer Registry, consisting of 7,000 families with more than 250,000 individuals and the recruitment of seven full-time genetic counselors.

• Established an historic research partnership with The Wistar Institute of Philadelphia, the first time an NCI-designated basic science center has aligned with an independent academic community cancer center on translational cancer research with the aim of bringing the latest discoveries in cancer research to cancer patients in our community.

• Established the Center for Translational Cancer Research, 7,000 sq. ft. of laboratory space where scientists and clinicians work together to find new cancer treatments.

• Established the Gene Editing Institute, a worldwide leader in gene editing and biomedical research in cancer and other inherited diseases, and the only one in the U.S. embedded in a clinical center where interactions among oncologists, genetic counselors and patients take place.

Dr. Petrelli has received numerous awards and has authored 343 peer-reviewed manuscripts. He has served on several advisory panels of the National Cancer Institute, the American Society of Clinical Oncology, the American Cancer Society and the Society of Surgical Oncology. He was President of the Society of Surgical Oncology 2007-2008. In 2013, he received the Order of the First State Award by Governor Jack Markell for his dedication to excellence in serving the community and the State of Delaware.

Previous recipients include:

2008 Victor F. Battaglia, Sr., Esq.
2009 Robert W. Frelick, M.D.
2010 Leslie W. Whitney, M.D.
2011 Robert B. Flinn, M.D.
2012 Edwin L. Granite, D.M.D.
2013 Katherine L. Esterly, M.D.
2014 LTG(DE) William H. Duncan, M.D.
2015 Joseph A. Kuhn, M.D.
2016 J. Kent Riegel, Esq.
2017 Hon. Susan C. Del Pesco

Innovative Discoveries Series

Law, Technology, and End-of-Life Planning

Advance directives (AD) were created as legal documents to help ensure that patients’ wishes are respected at the end of life.  However, their actual impact on end-of-life care is less clear.  Most people do not complete them, and they are often unavailable when needed.  Recent technological innovations have sought to reinvent ADs.  Tech start-ups offer tools to create and store digital ADs, and commercial electronic health record systems are expanding their functionality to store end-of-life wishes.  I trace the history of ADs, discuss the limitations of the legal model, and describe current efforts to digitize end-of-life planning.  I will focus in part on efforts at the University of Pennsylvania to develop an EHR-integrated online platform for documenting end-of-life plans.

Presented By:

Joshua Rolnick, MD, JD

General Internist and VA Advanced Fellow, National Clinician Scholars Program, University of Pennsylvania/Philadelphia VA Medical Center

Free!  Lunch will be served!

This activity has been approved for AMA PRA Category 1 Credit.

REGISTER ONLINE TODAY!

Friday, December 14, 2018
Noon to 1 p.m.
In-person: Christiana Hospital,Room 110
Online: Watch live at https://bluejeans.com/361095905
Or join meeting ID 361095905 on the BlueJeans app on your smartphone or tablet

This activity has been approved for AMA PRA Category 1 Credit.

Upcoming Lectures:

January 11, 2019: Beyond Rants, Raves, and Reputation: Using Patient Comments to Improve Care

Statement on Vaccines

Vaccines Continue to be Tested and Proven Safe

American Academy of Pediatrics. (2017). American Academy of Pediatrics Emphasizes Safety and Importance of Vaccines. Retrieved from https://www.aap.org/en-us/about-the-aap/aap-press-room/Pages/American-Academy-of-Pediatrics-Emphasizes-Safety-and-Importance-of-Vaccines.aspx

Centers for Disease Control and Prevention. (2016). Infant Immunizations FAQs. Retrieved from https://www.cdc.gov/vaccines/parents/parent-questions.html

Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. Retrieved from https://www.nap.edu/catalog/10997/immunization-safety-review-vaccines-and-autism

U.S. Food and Drug Administration. (2015).  Thimerosal in Vaccines: Questions and Answers. Retrieved from http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/UCM070430#q5

In light of recent claims by politicians or appointees that vaccines are linked to autism, or are unsafe when administered according to the recommended schedule, or contain dangerous products like Thimerosal, the public health community and the Delaware Academy of Medicine/Delaware Public Health Association continue to come down on the side of science.

The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research is responsible for regulating vaccines in the United States.  Before a vaccine can be licensed for public use, it must be tested for safety in the laboratory, in animals, and in human clinical trials.  Human clinical trials include looking for common adverse events in a few participants (phase 1), several hundred volunteers looking for local reactions and general side effects like fever (phase 2), and establishing the effectiveness of the vaccine and determining less common side effects with thousands of participants (phase 3).  If a vaccine is to be given at the same time as another vaccine, the two vaccines are tested together (FDA, 2015).  If a dangerous effect is found, that vaccine is not licensed for public use.

Vaccines are continuously monitored following licensure by the Vaccine Adverse Event Reporting System (VAERS), which is run by both the FDA and the Centers for Disease Control (CDC).  The VAERS is a national system that collects all reports of adverse events following vaccination.  Phase 4 clinical studies are also conducted to further evaluate the new vaccine, and population based studies are conducted through the use of databases like the Vaccine Safety Datalink (VSD) for the lifetime of the use of the vaccine (FDA, 2015).

The Institute of Medicine (IOM) Immunization Safety Review Committee “favors rejection of a causal relationship between thimerosal-containing vaccines and autism” (IOM, 2004).  Despite this finding, “all vaccines routinely recommended for children 6 years of age or younger and marketed in the U.S. contain no thimerosal or only trace amounts” (FDA, 2015).

“Infants and young children who follow immunization schedules that spread out shots – or leave out shots – are at risk of developing diseases during the time that shots are delayed” (CDC, 2016). Vaccines “keep communities healthy, and protect some of the most vulnerable in our society” (American Academy of Pediatrics, 2017).  The Delaware Academy of Medicine will continue to advocate for vaccines and vaccine use in the state of Delaware and the United States.

CCHS Global Health Residency Track

GLOBAL HEALTH SERIES

Please join us for this month’s global health talk!
The Global Health Residency Tracks of Christiana Care Health System, in partnership with the Delaware Academy of Medicine / Delaware Public Health Association, are pleased to invite you to this month’s global health talk.

Thursday, November 15, 2018
5:30 – 6:30 pm
LIVE: Ammon Medical Education Center Main Auditorium (broadcast to Room 2 in the Brandywine Conference Center at Wilmington Hospital).

Reduction in Maternal Mortality Through Advances in Prevention of Postpartum Hemorrhage

Postpartum hemorrhage remains a leading cause of maternal mortality worldwide. This talk presents an overview of this major global health issue, and key innovations from around the world. For the past decade, a large global research group has been conducting research and sharing best practices worldwide. Funded by the NIH and foundations, these innovations have helped shape MCH and GH policy.  Our group will have recently presented several papers on this topic at the annual meeting of the American Public Health Association (APHA).  We invite you to hear these updates, targeted at all levels of learners, professionals, and staff in the Christiana Care community.

Speaker:
Professor Shivaprasad Goudar
JN Medical College, India

Co-Hosts:
Dr. Matthew Hoffman
Dr. Omar Khan

REGISTER ONLINE

The CCHS Global Health Curriculum is an interdepartmental collaboration, supporting the Global Health Tracks in the Depts. of Medicine and Family Medicine, and the Med-Peds Residency, with the support of the Delaware Academy of Medicine, Delaware Public Health Association, and Delaware Academy of Family Physicians.

All are welcome to attend this talk.  Global Health Curriculum residents are required to attend.  There is no charge to attend this event, but registration is required. Food and Refreshments will be served.

Future Talks